Role of host immune factors as potential biomarkers for predicting response and resistance acquisition to palbociclib-based treatment in metastatic hormono sensitive breast cancer

Ver todos los proyectos

Proyecto - Activo

Role of host immune factors as potential biomarkers for predicting response and resistance acquisition to palbociclib-based treatment in metastatic hormono sensitive breast cancer

01.01.2021 - 31.12.2021

Investigadores/as principales: Ester Ballana Guix, Mireia Margelí
Back to Top
Irsi Caixa

Impulsado por:

Fundación 'La Caixa' Generalitat de Catalunya - Departament de Salut

 

HR Excellence in Research

Miembro de:

Cerca

Con la colaboración de: